Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis
- PMID: 18695713
- DOI: 10.1038/ncprheum0880
Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis
Comment on
-
Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials.J Rheumatol. 2008 May;35(5):883-90. Epub 2008 Mar 15. J Rheumatol. 2008. PMID: 18381787
Publication types
LinkOut - more resources
Full Text Sources